Influence of Some Formulation Variables on the Optimization of pH-dependent, Colon-targeted, Sustained-release Mesalamine Microspheres

Abstract

Abstract. The aim of this work was to understand the influence of different formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres prepared by O/O emulsion solvent evaporation method, employing pH-dependent Eudragit S and hydrophobic pHindependent ethylcellulose polymers. Formulation variables studied included concentration of Eudragit S in the internal phase and the ratios between; internal to external phase, drug to Eudragit S and Eudragit S to ethylcellulose to mesalamine. Prepared microspheres were evaluated by carrying out in vitro release studies and determination of particle size, production yield, and encapsulation efficiency. In addition, morphology of microspheres was examined using optical and scanning electron microscopy. Emulsion solvent evaporation method was found to be sensitive to the studied formulation variables. Particle size and encapsulation efficiency increased by increasing Eudragit S concentration in the internal phase, ratio of internal to external phase, and ratio of Eudragit S to the drug. Employing Eudragit S alone in preparation of the microspheres is only successful in forming acid-resistant microspheres with pulsatile release pattern at high pH. Eudragit S and ethylcellulose blend microspheres were able to control release under acidic condition and to extend drug release at high pH. The stability studies carried out at 40°C/75% RH for 6 months proved the stability of the optimized formulation. From the results of this investigation, microencapsulation of mesalamine in microspheres using blend of Eudragit S and ethylcellulose could constitute a promising approach for site-specific and controlled delivery of drug in colon.

Skimmed milk powder and pectin decorated solid lipid nanoparticle containing soluble curcumin used for the treatment of colorectal cancer

“…Dissolution kinetic studies of the SLN formulation were supported using zero‐order, first‐order equations, and to better depict the mechanism of drug release, Higuchi, Hixson Crowell, Korsmeyer Pappas, and release exponent (n) equation models were applied. The regression coefficient factors ( r 2 ) were calculated to identify the kinetic release performance of prepared SLNs formulations (El‐Bary, Aboelwafa, & Sharabi, ).…”

Colon specific drug delivery of mesalamine using eudragit S100-coated chitosan microspheres for the treatment of ulcerative colitis

“…At the end of fourth hour pH was raised to 7.4 by adding 300 ml of phosphate buffer concentrate (2.18 g of KH2PO4 and 1.46 g of NaOH in distilled water) (El-Bary et al, 2012). At predetermined time intervals, 5 ml sample was withdrawn, passed through a 0.45 µm membrane filter (Millipore).…”

Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper–Lin small composite design

“… 3 , 4 Many formulation and processing variables could be involved in the preparation of microspheres by the ESE method, eg, the molecular weight of the polymers and the viscosity of the polymeric solution, 5 solvent mixture composition, and stirring speed. 6 Also, the drug to polymer ratio affects the properties of the prepared microspheres, 7 , 8 while the concentration of polymer, drug to polymer ratio, percentage of the surfactant, and pore inducing agent affect the release and properties of microcapsules. 9 In a different study, the yield, the size of microspheres, and the release rate were increased by the addition of a nonsolvent.…”